Literature DB >> 29788346

Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Olamide D Jarrett1, Jane F Seward1, Augustin E Fombah2, Robert Lindblad3, Mohamed I Jalloh2, Jill El-Khorazaty3, Peter Dawson3, Deron Burton1, Jane Zucker1, Wendy Carr1, Mohamed M Bah2, Gibrilla F Deen2, Peter M George2, Faustine James2, Durodami R Lisk2, Dudley Pratt2, James B W Russell2, Jibao D Sandy2, Patrick Turay2, Mary J Hamel1, Stephanie J Schrag1, Robert E Walker4, Mohamed Samai2, Susan T Goldstein1.   

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29788346      PMCID： PMC5961367          DOI： 10.1093/infdis/jiy042

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  11 in total

1.  Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Authors:  Selidji T Agnandji; Angela Huttner; Madeleine E Zinser; Patricia Njuguna; Christine Dahlke; José F Fernandes; Sabine Yerly; Julie-Anne Dayer; Verena Kraehling; Rahel Kasonta; Akim A Adegnika; Marcus Altfeld; Floriane Auderset; Emmanuel B Bache; Nadine Biedenkopf; Saskia Borregaard; Jessica S Brosnahan; Rebekah Burrow; Christophe Combescure; Jules Desmeules; Markus Eickmann; Sarah K Fehling; Axel Finckh; Ana Rita Goncalves; Martin P Grobusch; Jay Hooper; Alen Jambrecina; Anita L Kabwende; Gürkan Kaya; Domtila Kimani; Bertrand Lell; Barbara Lemaître; Ansgar W Lohse; Marguerite Massinga-Loembe; Alain Matthey; Benjamin Mordmüller; Anne Nolting; Caroline Ogwang; Michael Ramharter; Jonas Schmidt-Chanasit; Stefan Schmiedel; Peter Silvera; Felix R Stahl; Henry M Staines; Thomas Strecker; Hans C Stubbe; Benjamin Tsofa; Sherif Zaki; Patricia Fast; Vasee Moorthy; Laurent Kaiser; Sanjeev Krishna; Stephan Becker; Marie-Paule Kieny; Philip Bejon; Peter G Kremsner; Marylyn M Addo; Claire-Anne Siegrist
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

2.  A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Authors:  Jason A Regules; John H Beigel; Kristopher M Paolino; Jocelyn Voell; Amy R Castellano; Zonghui Hu; Paula Muñoz; James E Moon; Richard C Ruck; Jason W Bennett; Patrick S Twomey; Ramiro L Gutiérrez; Shon A Remich; Holly R Hack; Meagan L Wisniewski; Matthew D Josleyn; Steven A Kwilas; Nicole Van Deusen; Olivier Tshiani Mbaya; Yan Zhou; Daphne A Stanley; Wang Jing; Kirsten S Smith; Meng Shi; Julie E Ledgerwood; Barney S Graham; Nancy J Sullivan; Linda L Jagodzinski; Sheila A Peel; Judie B Alimonti; Jay W Hooper; Peter M Silvera; Brian K Martin; Thomas P Monath; W Jay Ramsey; Charles J Link; H Clifford Lane; Nelson L Michael; Richard T Davey; Stephen J Thomas
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

3.  Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors:  Rosalind J Carter; Ayesha Idriss; Marc-Alain Widdowson; Mohamed Samai; Stephanie J Schrag; Jennifer K Legardy-Williams; Concepcion F Estivariz; Amy Callis; Wendy Carr; Winston Webber; Marc E Fischer; Stephen Hadler; Foday Sahr; Melvina Thompson; Stacie M Greby; Joseph Edem-Hotah; Roselyn M'baindu Momoh; Wendi McDonald; Julianne M Gee; Ahamed Flagbata Kallon; Dayo Spencer-Walters; Joseph S Bresee; Amanda Cohn; Sara Hersey; Laura Gibson; Anne Schuchat; Jane F Seward
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

4.  Factors associated with mortality in febrile patients in a government referral hospital in the Kenema district of Sierra Leone.

Authors:  Prerana J Roth; Donald S Grant; Amara S Ngegbai; John Schieffelin; R Scott McClelland; Olamide D Jarrett
Journal:  Am J Trop Med Hyg       Date:  2014-11-17       Impact factor: 2.345

5.  Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.

Authors:  Scott A Halperin; Jose R Arribas; Richard Rupp; Charles P Andrews; Laurence Chu; Rituparna Das; Jakub K Simon; Matthew T Onorato; Kenneth Liu; Jason Martin; Frans A Helmond
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

6.  The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.

Authors:  Angela Huttner; Julie-Anne Dayer; Sabine Yerly; Christophe Combescure; Floriane Auderset; Jules Desmeules; Markus Eickmann; Axel Finckh; Ana Rita Goncalves; Jay W Hooper; Gürkan Kaya; Verena Krähling; Steve Kwilas; Barbara Lemaître; Alain Matthey; Peter Silvera; Stephan Becker; Patricia E Fast; Vasee Moorthy; Marie Paule Kieny; Laurent Kaiser; Claire-Anne Siegrist
Journal:  Lancet Infect Dis       Date:  2015-08-04       Impact factor: 25.071

7.  Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.

Authors:  Stephen B Kennedy; Fatorma Bolay; Mark Kieh; Greg Grandits; Moses Badio; Ripley Ballou; Risa Eckes; Mark Feinberg; Dean Follmann; Birgit Grund; Swati Gupta; Lisa Hensley; Elizabeth Higgs; Krisztina Janosko; Melvin Johnson; Francis Kateh; James Logue; Jonathan Marchand; Thomas Monath; Martha Nason; Tolbert Nyenswah; François Roman; Eric Stavale; Julian Wolfson; James D Neaton; H Clifford Lane
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

8.  Implementing an Ebola Vaccine Study - Sierra Leone.

Authors:  Marc-Alain Widdowson; Stephanie J Schrag; Rosalind J Carter; Wendy Carr; Jennifer Legardy-Williams; Laura Gibson; Durodami R Lisk; Mohamed I Jalloh; Donald A Bash-Taqi; Samuel A Sheku Kargbo; Ayesha Idriss; Gibrilla F Deen; James B W Russell; Wendi McDonald; Alison P Albert; Michelle Basket; Amy Callis; Victoria M Carter; Kelli R Clifton Ogunsanya; Julianne Gee; Robert Pinner; Barbara E Mahon; Susan T Goldstein; Jane F Seward; Mohamed Samai; Anne Schuchat
Journal:  MMWR Suppl       Date:  2016-07-08

9.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321

10.  Diagnosis of Febrile Illnesses Other Than Ebola Virus Disease at an Ebola Treatment Unit in Sierra Leone.

Authors:  Matthew K O'Shea; Kate A Clay; Darren G Craig; Steven W Matthews; Raymond L C Kao; Thomas E Fletcher; Mark S Bailey; Emma Hutley
Journal:  Clin Infect Dis       Date:  2015-05-19       Impact factor: 9.079
View more
  4 in total

1.  Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Authors:  Augustin E Fombah; Susan T Goldstein; Olamide D Jarrett; Mohamed I Jalloh; Jill El-Khorazaty; Durodami Radcliffe Lisk; Jennifer Legardy-Williams; Dudley A Pratt; Peter M George; James B W Russell; Stephanie J Schrag; Peter Dawson; Gibrilla F Deen; Wendy Carr; Robert Lindblad; Faustine James; Mohamed M Bah; John F Yillia; Jibao D Sandy; Patrick E Turay; Muhammad-Abbas Conteh; Laurence Slutsker; Barbara E Mahon; Mohamed Samai; Jane F Seward
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

2.  Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors:  Muhammad-Abbas Conteh; Susan T Goldstein; Haja R Wurie; Jane Gidudu; Durodami Radcliffe Lisk; Rosalind J Carter; Jane F Seward; Lee M Hampton; David Wang; Lauren E Andersen; Melissa Arvay; Stephanie J Schrag; Peter Dawson; Augustin E Fombah; Carey R Petrie; Daniel R Feikin; James B W Russell; Robert Lindblad; S A S Kargbo; Mohamed Samai; Barbara E Mahon
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

Review 3.  Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?

Authors:  Yuguo Zhang; Bolni Marius Nagalo
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

4.  Precision global health and comorbidity: a population-based study of 16 357 people in rural Uganda.

Authors:  Goylette F Chami; Narcis B Kabatereine; Edridah M Tukahebwa; David W Dunne
Journal:  J R Soc Interface       Date:  2018-10-31       Impact factor: 4.118
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.